Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
The dual GLP-1 and GIP action provides enhanced appetite suppression and metabolic support, helping you achieve sustainable weight loss when combined with a healthy diet and exercise
Clinical studies indicate that some patients may experience weight loss as early as two weeks after starting Zepbound, though the most significant and sustained results typically become noticeable after four to eight weeks
Below is a summary of key published data points researchers should reference when evaluating these two compounds
Advantages Most powerful weight-loss medication currently available Excellent HbA1c reduction Strong appetite suppression Superior weight-loss outcomes compared with semaglutide Limitations Highest cost Not affordable for every patient Which Medication Produces More Weight Loss
PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) flat
Lilly cannot validate the safety or effectiveness of products claiming to contain tirzepatide that are not our own branded product. Mounjaro, which is approved to treat Type 2 diabetes, is manufactured by and commercially available only through Eli Lilly
US$ 26.69
US$ 29.93
US$ 20.88
US$ 26.82
US$ 21.32
US$ 21.07
US$ 26.46
